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ABSTRACT 
The  correlation between  malignant transformation and  increased plasminogen 
activator  synthesis has  been  studied  io  a  variety of established  cell  lines.  In 
contrast to the behavior of secondary mouse embryo cultures, which always show 
increased fibrinolytic activity when transformed, no such correlation was found 
within  the  BALB/c 3T3  line  and  its  transformed derivatives.  Cell  lines  were 
established from tumors initiated in  BALB/c mice by several transformed cell 
lines. These lines were generally found to contain no more plasminogen activator 
than the cells used for inoculation. A correlation was found between transforma- 
tion and plasminogen activator synthesis within Swiss 3T3 cell lines. However, the 
correlation was not maintained by serum revertants of transformed Swiss 3T3 
cells. 
The production of plasminogen activators (PA) by 
primary  fibroblasts  transformed  to  malignancy 
and  the  consequent ability of these  cells to  pro- 
mote the hydrolysis of fibrin via the activation of 
plasminogen to plasmin has been demonstrated to 
occur in a variety of cell types (3,  6,  10,  13,  14, 
20). Thus, the fibroblasts of chicken, mouse, ham- 
ster,  rat,  and  human  all  secrete  appreciable 
amounts of plasminogen activators after transfor- 
mation by  either viruses or chemicals, while the 
parental cells produce rather little of this enzyme. 
Although the majority of cells employed in these 
studies had been in culture for only a few genera- 
tions,  a  significant proportion  of in  vitro experi- 
ments  on  transformation  utilize  nontransformed 
and  transformed  pairs  of  established  cell  lines 
rather than primary cells and their transformants. 
Since cell lines are  isolated after long periods in 
culture  and  almost always have  abnormal  karyo- 
types, it was of interest to determine whether the 
correlation between transformation and increased 
PA production also applied to cell lines. We have 
found that the correlation does not rigorously hold 
for  two  sets  of mouse  cell lines.  The  cells from 
some nonmalignant cell lines contain high levels of 
PA,  while, conversely, certain  transformed  cells 
derived from them may contain low levels of PA. 
MATERIALS AND  METHODS 
Cells and Virus (Table I) 
Swiss 3T3 and the Simian virus 40 (SV40) transformant 
SV101 cell lines were originally derived by Todaro and 
Green  (18).  The FlSVll is a flat revertant  of SV101 
(11). The Col 2,  and A~,7, and the  LS6 revertants  of 
SV101 were  isolated by  Vogel and  Pollack (21),  and 
Vogel et ai. (22). The BALB 3T3 clone A31CL10 was a 
generous gift from Dr. E. Scolnick (National Institutes of 
Health,  Bethesda,  Md.)  as  were  the  following trans- 
formed derivatives of this clone: SVT~, and SV40 trans- 
formant;  KA31,  a Kirsten sarcoma virus transformant; 
KA/RLV, a KA31 transformed clone also infected with 
Rauscher leukemia virus; B77A31,  a clone transformed 
by B77 avian sarcoma virus; FSV/RLV,  a clone trans- 
formed  by  feline  sarcoma  virus  and  coinfected  with 
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Properties of Cells Used 
Name  Species of origin  Transforming agent 
Tumorigenicity" 
Phenotype  104,  10~ 
BALB/c 3  0 
4-71-1 
A31CL10 
SVT2 
KA31 
Ki/RLV 
B77 
PYA31 
R4-4 
FSV/RLV 
BALB/c mouse primary 
BDIX rat 
BALB/c established  cell line 
A31 
S+t -  ,, 
3T3  Swiss mouse established cell 
line 
SV101  3T3  SV40 virus 
F1SVll  SV101 
Col 2  " 
Ay7  " 
LS6 
Ethyinitrosourea 
SV40 virus 
Kirsten sarcoma virus 
Kirsten  sarcoma  virus  and 
Rauscher leukemia  virus 
B77  avian sarcoma virus 
Polyoma virus 
Radiation 
Feline  sarcoma  virus  and 
Rauscher  leukemia  virus 
Moloney sarcoma virus 
Normal 
Transformed 
Normal 
Transformed 
Normal 
Transformed 
Normal 
NDw 
0/5 II 
1/5 
3/5 
2/5 
2/5 
1/5 
3/5 
3/5 
2/5 
ND 
0/7 
ND 
0/5 II 
ND 
2/2 
ND 
0/4￿82 
5/6￿82 
0/2￿82 
ND￿82 
2/4￿82 
0/2￿82 
* Animals with tumors/total animals tested. 
~: D. B. Rifkin, unpublished observations and this study. 
w  ND is not determined. 
I[ Under certain conditions these cells may form tumors (see reference 2). 
￿82  Determined in the nude mouse (17). 
Rauscher leukemia virus;  RLV, a  clone infected with 
Rauscher leukemia virus;  R4-4, a clone transformed by 
radiation;  S+L  -,  a  clone  of cells  transformed by  the 
Moloney sarcoma virus. The polyoma virus transformant 
of A31, PYA31, was generously given to us by Dr. T. 
Benjamin,  (Harvard  Medical  School,  Cambridge, 
Mass.). The KA/RLV, FSV/RLV, and RLV cell lines 
continuously produced  infectious virus.  All  other cell 
lines did not produce virus. A31, Swiss 3T3, SV101, and 
all revertants were doubly recloned approx. 3 mo before 
these experiments. 
Tumor-derived sublines  of  the  cell  lines  described 
above were isolated after injecting 10  a, 10  ~, or 105 trans- 
formed cells into 3-wk-old BALB/c mice. The mice were 
checked for tumors by palpation every 3-4 days. When a 
palpable mass was detected, it was surgically removed, 
minced, trypsinized in 0.25% trypsin, 0.001  M EDTA, 
and the cells were plated in Dulbecco's modified Eagle's 
medium (Grand Island Biological Co., Grand Island, N. 
Y.) containing 10% fetal bovine serum (Reheis Chemi- 
cal  Co.,  Chicago, I11.). Each  tumor-derived subline is 
denoted by  a  T  after  the  abbreviation  used  for  the 
parental cell line. 
Primary BALB/c cells were obtained after trypsiniza- 
tion of decapitated 16-day-old  mouse embryos. At con- 
fluence, the cells were trypsinized, frozen, and stored in 
liquid  nitrogen until further use. 
The 4-71-1 cells were obtained from a rat neurotumor 
induced by ethylnitrosourea in a BDIX rat and were a 
gift from Dr. N. Sueoka (University of Colorado, Boul- 
der,  Colo.). These cells  have been found to  produce 
exceptionally  high levels of PA and are used as a stan- 
dard reference line  for high  PA production. Rauscher 
leukemia virus (RLV195) was a gift of Dr. E. Scolnick. 
All cells were grown in Dulbecco's modified medium 
containing 10% fetal bovine serum (DBFC10) and tylo- 
sin (60/zg/ml) (Associated Biomedic Systems, Inc., Buf- 
falo, N.  Y.). The medium was changed twice  a week. 
The cells were passaged once each week at a dilution of 
1:20.  All cells were grown at 37~  in an atmosphere of 
10% CO2, 90% air with a relative humidity of 100%. 
Secondary BALB/c cells were infected with virus after 
they were first incubated with DEAE-Dextran, 20 tzg/ml 
in 2 ml of TD buffer (0.14 M NaCI, 0.005 M KCI, 0.024 
Tris-HCl, and 0.0004 M Na~HPO4, pH 7.4), for 45 min 
at 37~  The DEAE-Dextran was then removed, and 2 
ml  of culture  medium  obtained from  virus-producing 
cells was placed in each  100-mm dish. The cells were 
incubated for an additional 1 h at 37~  At the end of 
this period, 10 ml of DBFC10 was added to each plate. 
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The preparation of nsI-fibrin plates was performed as 
described by Unkeless et al. (20) and Beers et al.  (1). 
Secretion of plasminogen activator by  living  cells  was 
assayed as follows: cells were dispersed by mild trypsin 
treatment, suspended in Eagle's minimal medium con- 
taining 10% fetal bovine serum (EFC10), centrifuged at 
500 g  for 5 min, resuspended in EFC10, and plates on 
17  mm 125I-fibrin-coated dishes (Linbro Chemical Co., 
New Haven, Conn.). The cells 5 x  104 were allowed to 
attach for 6 h, the medium was removed, the cells were 
washed once with TD buffer, and 1 ml of Eagle's mini- 
mal  medium  containing  the  appropriate  serum  was 
added. Duplicate assays were performed in the presence 
of 2.5% dog serum, 10% fetal bovine serum, or medium 
alone, The plates were then incubated at 37~  and, at 
the indicated items, 0.5-ml aliquots of the medium were 
removed. The amount of soluble 125I-fibrin liberated by a 
given cell line was determined by counting each aliquot 
in a Packard y-counter (Packard Instrument Co., Inc., 
Downers Grove, Ill.). 
Total cell-associated  levels of PA were assayed in the 
following  manner  (13).  Initially,  5  x  105  cells  were 
plated in 60-mm petri dishes and allowed to grow for 24 
h. The medium was then removed, and the cells were 
washed twice with TD buffer and incubated at 37~  in 
serum-free Eagle's minimal medium for 3 h. The serum- 
free medium was removed, and the cells were washed 
twice with ice-cold TD buffer and scraped with a rubber 
policeman. The scraped cells were suspended in approx. 
10 ml of ice-cold TD buffer, centrifuged at 2,000 g for 5 
min, and the supernate was discarded. The cell pellet was 
dissolved in 0.1  M Tris-HC1,  0.5%  Triton X-100, pH 
8.1, centrifuged at 500 g for 10 min, and the supernate, 
which contained greater than 90% of the total PA, was 
removed for PA assays.  The protein concentration was 
determined by the method of Lowry et al. (8). Measured 
aliquots of the cell extract were added to 17 l~I-fibrin- 
coated  plates  containing  0.5  ml  of  0.1  M  Tris-HCl 
buffer, pH  8.1,  and  4  /.~g/ml of purified fetal bovine 
plasminogen. Plasminogen was purified according to the 
method of Deutsch and Mertz (5) and was at least 95% 
pure as judged by SDS-polyacrylamide gel electrophore- 
sis. The assays were performed at 37~  At the appropri- 
ate times, aliquots of the assay  reaction were removed 
and  the  ~2Sl-content was  determined in  a  Packard y- 
counter. The background levels of fibrinolysis with con- 
trols of plasminogen alone or Triton X-100 extract alone 
were never more than 3 % of the total counts removed by 
trypsin (25  p.g/ml). The values for the plasminogen con- 
trol were subtracted from each sample value. 
The  secretion of soluble plasminogen activator was 
measured in cell cultures prepared as described for the 
assay of intracellular  plasminogen activator except that 
the incubation in  serum-free minimal Eagle's medium 
was continued for 24 h. During this period, aliquots of 
medium were  periodically  removed from the  cultures 
and frozen. The assays for PA were then performed in 
the same way as those described for intraceUular  plas- 
minogen activator except that  0.1-ml  samples of the 
serum-free, conditioned Eagle's medium were used in 
place of cell lysates. 
A unit of plasminogen activator activity is the amount 
of enzyme which will catalyze  the release of 5 % of the 
substrate radioactivity  in  1 h at 37~  using 4/zg/ml of 
fetal bovine plasminogen in 1.0 ml of 0.1  M Tris-HCl, 
pH 8.1 in a 17-ram petri dish. The total substrate radio- 
activity  was  determined by  measuring the  amount  of 
12U-fibrin solubilized  by  1 ml of 0.25%  trypsin at  pH 
7.6 in 1 h. 
The different levels of fibrinolysis associated with var- 
ious cell lines tested were not merely the result of differ- 
ential cell plating or growth. Cell counts at the initiation 
and conclusion of each experiment varied by no more 
than 20%. Moreover, as has been described before (10), 
cells which produce high levels of PA over long periods 
of time tend to detach from the surface of the petri dish. 
Consequently, those  assay  plates containing cell  lines 
having  the highest fibrinolytic  activity  always contained 
fewer cells at the termination of an experiment than cell 
lines producing low levels of PA. 
It should be noted that the figures and tables present 
only the level  of fibrinolysis  generated by cells in  dog 
serum. Each cell  line  was also tested for its ability  to 
hydrolyze fibrin in the absence of serum as well as in the 
presence of fetal bovine serum. As has been described 
elsewhere (10,  14, 20), fibrinolysis was strictly depend- 
ent upon the presence of plasminogen. No more than 
3%  of the substrate was hydrolyzed in the absence of 
plasminogen.  In  addition,  the  amount  of  proteolysis 
when fetal bovine serum was employed was about 10% 
of that  found  with  dog  serum.  This  result  is  also  in 
agreement with earlier results with other rodent ceils (3, 
10,  13). 
No attempt has been made to analyze the kinetics of 
the reaction as they are obviously  complex and would 
not be expected to follow simple enzyme kinetics.  The 
substrate employed is insoluble, and the assay is a cou- 
pled one employing two proteases; in some cases, there 
is continuous elaboration of plasminogen activator, and 
the end product of the reaction, plasmin, will destroy 
plasminogen activator. Repeated assays of the same cell 
line  may vary in  absolute activity,  as can  be seen by 
comparing the activity  of B77  in  Figs.  1 and 2.  Such 
variation may be due, in part, to the state of the fibrin 
substrate. However, each assay is performed with stan- 
dard  cells,  and,  relative  to  these  standard  lines,  the 
differences between different cell lines have always been 
constant. This is true for some cell lines which have been 
compared several times over a three-year period. While 
the activities measured may have been the result of the 
release of proteases other than plasminogen activator, 
dependence of fibrinolysis upon the presence of plasmin- 
ogen would indicate that any plasminogen-independent 
hydrolysis of the substrate must be a minor activity. 
D.  B.  RIFKIN AND  R.  POLLACK  Plasminogen Activator in Cell Lines  49 RESULTS 
Fibrinolysis by BALB/c 3T3 cells 
and BALB/c 3T3 transformants 
One of the cell lines widely used in tissue culture 
is the BALB/c 3T3 line and its transformed deriv- 
atives. When cells of the A31 clone of the BALB/ 
c 3T3 line were plated on 125I-fibrin-coated plates, 
it  was  found  that  the  untransformed  cells 
(A31CL10)  generated  significantly more  fibrino- 
lysis  than  third  passage  BALB/c  embryo  cells 
(BALB/c 3 ~  (Fig. 1 A), but considerably less than 
malignant  4-71-1  cells.  In the  absence  of serum, 
there was no fibrinolysis (Fig.  1 A). 
SVT2, an SV40 virus transformant  of the A31 
clone,  had  a  higher  fibrinolytic  activity than  the 
parental A31 cells as did the Kirsten sarcoma virus 
transformant  KA31  (Fig.  1 B). This is consistent 
with previous observations with other normal and 
transformed  cells.  However,  a  number  of other 
lines  displaying  transformed  characteristics  de- 
rived from A31  by irradiation (R4-4) or by infec- 
tion with different tumor viruses produced  levels 
of fibrinolysis either  equivalent to  or lower than 
that  associated  with  the  parental  A31CL10  cells 
(Fig.  1 A  and B). 
The  variation  in  PA  production  evident when 
lines were plated on lzsI-fibrin was also apparent 
when the total cell-associated plasminogen activa- 
tor or the secretion of soluble  PA (Table  II) was 
assayed. Attempts to detect plasminogen activator 
or  plasmin  inhibitors  associated  with  those  cell 
lines containing low levels of plasminogen activa- 
tor  have  thus  far  been  unsuccessful.  Thus,  the 
differences in the fibrinolytic activities illustrated 
in Fig.  1 and Table II are indicative of differences 
in  the  levels  of  synthesis  and  secretion  of  PA. 
Since some  of the  cell lines tested  failed to  pro- 
duce  or secrete  PA but were indeed tumorigenic 
(see below), the correlation between tumorigenic 
transformation and increased levels of PA synthe- 
sis does  not  hold for this set  of transformed  cell 
lines. 
Since the transformed cell lines used above were 
all selected by various in vitro criteria of transfor- 
mation  (15),  it was  important  to  establish  which 
of these A31CL10-derived lines were tumorigenic 
and  to  determine  the  fibrinolytic  activity of cell 
lines derived from these tumors.  Cells from most 
of the  cell lines rapidly  formed  tumors  when  in- 
jected into 2-wk-old BALB/c mice. (While all of 
the transformed  cell lines 6aused  tumors in vitro, 
we  were  not  able  to  culture  in vitro all of these 
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FIGURE  1  Fibrinolytic  activity  of  the  BALB/c  3T3 
(A31CL10) cell line and transformed derivatives of this 
cell line. The fibrinolytic  activity of living cells plated on 
nsI-fibrin coated surfaces was determined as described in 
Materials and  Methods.  The data  presented  represent 
those values found for cells grown in medium containing 
2.5% dog serum. The level of fibrinolysis seen when the 
cells  were  incubated  on  ~25I-fibrin in  the  absence  of 
serum is illustrated (4-71-1  NS) for the 4-71-1  cell line. 
A31CL10 is a nontransformed line of BALB/c 3  ~ ceils, 
Ki/RLV is a  KA31  clone also infected with Rauscher 
leukemia virus, B77 is a B77 avian sarcoma virus trans- 
formant of A31CL10 cells,  PYA31  is a polyoma virus 
transformant  of A31CL10  cells,  R4-4  is  a  radiation- 
induced transformant of A31CL10 cells, FSV/RLV is a 
clone of A31CL10 cells coinfected with feline sarcoma 
virus and Rauscher leukemia virus, and S+L- is a clone 
of  A31CL10  cells  transformed  by  Moloney  sarcoma 
virus. 
tumors.)  These  included  the  KA31,  KI/RLV, 
FSV/RLV, S+L  -, and B77 cell lines. 
When  cell lines derived from the  tumors  were 
compared to the parental  cell lines (Fig. 2, Table 
III),  it  was  apparent  that  there  was  no  specific 
selection  for  cells containing  either  increased  or 
decreased  levels  of  PA.  In  most  instances,  the 
amount of PA in the tumor-derived cell lines was 
virtually identical to that found in the parental cell 
lines.  Nor  was  there  an  obvious  correlation  be- 
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Plasminogen Activator Levels of BALB/c 3T3 Cell 
Lines 
Release of soluble 
plasminogen  activa-  Total cell-associated  plas- 
Cell type  tor  minogen activator 
Ulml/lO h  U/mg 
A31CL10  7  178 
4-71-1  52  1,480 
BALB/c 3 ~  1  38 
SVT2  28  130 
KA31  27  240 
Ki/RLV  11  136 
B77  11  148 
PYA31  9  140 
R4-4  0  0 
FSV/RLV  0  0 
S§  -  0  0 
The release of soluble plasminogen activator  and total 
cell-associated  plasminogen  activator  were  assayed  as 
described in Materials and Methods. For the determina- 
tion of soluble plasminogen activator,  100  /~1 of condi- 
tioned medium were assayed after 10-h incubation of the 
cells in serum-free Eagle's medium. For the determina- 
tion of total cell-associated plasminogen activator, 5  /zg 
or  100  /zl  of each sample was assayed. The data illus- 
trated  were  taken  from  a  4-h  assay.  A31CL10  is  a 
nontransformed  line  of  BALB/c  ~  cells,  Ki/RLV  is  a 
KA31 clone also infected with Rauscher leukemia virus, 
B77  is  a  B77  avian  sarcoma  virus  transformant  of 
A31CL10 cells, PYA31 is a polyoma virus transformant 
of A31CL10  cells,  R4-4  is a  radiation  induced  trans- 
formant  of  A31CL10  cells,  FSV/RLV  is  a  clone  of 
A31 CL10 cells coinfected with feline sarcoma virus and 
Rauscher  leukemia  virus,  and  S§  -  is  a  clone  of 
A31CL10 cells transformed by Moloney sarcoma virus. 
tween  plasminogen activator levels and tumori- 
genic potential as determined by the  number of 
cells required to form a tumor or the frequency of 
tumors (data not shown). 
It was important to eliminate the possibility that 
cells producing high levels of PA were lost during 
the in vitro establishment of tumor sublines since 
experiments, in which MTV-, DMBA-, or RSV- 
induced tumors and cells derived from these  tu- 
mors were  assayed, have uniformly yielded high 
levels of fibrinolysis in well over 200 tumors each 
tested individually (reference 20; D.  Rifkin, un- 
published observations; and A. Piperno, unpub- 
lished  observations).  Therefore,  extracts  were 
made from several of the tumors upon excision, 
and the level of PA in each extract was compared 
to  that  found when cells from  the  same  tumor 
were grown in culture. The amount of PA associ- 
ated with these tumors was low and was compara- 
ble to the activities associated with the tumor cell 
lines after culture (results not shown). Thus, not 
only were some of the original cell lines with low 
PA levels tumorigenic, but also no selection for 
cells producing high levels of PA occurred during 
tumorigenesis. 
Infection of Secondary Mouse Cells 
with Virus Recovered from Transformed 
Cell Lines 
To  establish  that  the  low  fibrinolytic activity 
associated with certain cell lines was not the result 
of transformation by a virus genetically incapable 
of inducing the synthesis of PA, BALB/c second- 
ary cells were  infected with virus collected from 
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FIcuv.E  2  Fibrinolytic activity of the BALB/c 3T3 cell 
line A31CL10, transformed derivatives of this cell line, 
and  in  vitro  derived  sublines of these malignant cells. 
The in vitro derived sublines are denoted by a T after the 
cell line abbreviation.  The fibrinolytic activity of living 
cells plated on 125I-fibrin coated surfaces was determined 
as described in Materials and Methods and the legend to 
Fig.  1. 
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Plasminogen Activator Levels in Transformed 
BALB/c 3T3 lines and Tumor-Derived Sublines 
Release of soluble  plas-Total  cell-associated  plasmino- 
Cell type  minogen activator  gen activator 
U/rrd/lO h  U/mg 
4-71-1  50  1,132 
BALB/c 3  ~  0  36 
Ki/RLV  17  100 
Ki/RLV T15  13  58 
B77  15  258 
B77 T83  17  286 
KA31  9  216 
KA31 T122  4  78 
KA31 T128  3  162 
S+L  -  0  64 
S+L-T66  0  72 
S+L-T40  0  74 
FSV/RLV  0  28 
FSV/RLV T98  0  28 
The release of soluble plasminogen activator and total 
cell-associated  plasminogen  activator were  assayed  as 
described in Materials and Methods and the legend to 
Table I. 
cultures of the Ki/RLV, FSV/RLV, and RLV cell 
lines. 
The  infected cells  were  passaged  once  and as- 
sayed for the production of PA (Table IV). Con- 
sistent with the finding in other systems that only 
sarcoma viruses are  capable of inducing the  pro- 
duction of PA in fibroblasts (10, 20), there was no 
increase in the production of PA by cells infected 
with RLV.  After infection with either a  stock of 
Ki/RLV virus grown on primary BALB/c cells or 
culture  fluid obtained from the  Ki/RLV  cells,  or 
FSV/RLV,  the  morphology  of  the  cells  was  al- 
tered  and  the  amount  of PA  increased  dramati- 
cally (Table IV). Thus, although the Ki/RLV and 
FSV/RLV  cell  lines  do  not  produce  significant 
amounts of PA, the virus produced by these cells 
retains the capability of causing an increased syn- 
thesis  of  PA  upon  transformation  of  secondary 
BALB/c mouse embryo cells. 
Fibrinolysis by Swiss 3T3  Cells and 
Derivatives of Swiss 3 T3  Cells 
We  also  examined  the  fibrinolytic activities of 
another group of mouse cell lines: the Swiss 3T3 
cell line, an SV40 complete transformant of these 
cells, SV101,  and partial revertants of SV101  se- 
lected by three  different procedures.  In Table  V 
and Fig. 3 are shown the results of experiments to 
determine the total cell-associated,  secreted,  and 
intracellular plasminogen activator levels in these 
cells. The SV40 transformed cells had more activ- 
ity than the parental 3T3  cells.  When the revert- 
ants of SV101 were examined for PA production, 
a  complex pattern was observed. Thus, F1SV11, 
selected  by  its  inability  to  grow  at  high  density 
(11),  and Col 2,  selected by its resistance to col- 
chicine  (21),  both had lost the  high level of PA 
production  associated  with  the  SV101  parental 
TABLE IV 
Fibrinolytic Activity of BALB/c Cells Infected with 
RNA Tumor Viruses 
Cells  Substrate removed 
% 
1.4 
3.1 
46.4 
BALB/c tertiary 
BALB/c  tertiary  infected with  Ki/RLV 
from primary mouse cells 
Ki/RLV  3.5 
BALB/c tertiary infected with virus from  19.6 
Ki/RLV cells 
FSV/RLV  1.2 
BALB/c tertiary infected with virus from  17.5 
FSV/RLV cells 
BALB/c tertiary infected with RLV  2.3 
The fibrinolytic activity of control and virus-infected cells 
was determined as described in Materials and Methods. 
The data represent the amount of substrate hydrolyzed 
by intact cells after 16 h incubation in medium containing 
2.5% dog serum. The total radioactivity in each sample 
well  was  47,000  cpm.  The  RLV  was  prepared  after 
infecting BALB/c 3T3 cells with RLV (195). 
TABLE  V 
Plasminogen Activator Levels in Transformed Swiss 
3T3 Cell Lines 
Release of soluble plas- Total  cell-associated  piasmino- 
Cell type  minogen activator  gen activator 
U/ral/l  0 h  U/mg 
4-71-1  50  1,338 
BALB/c 3  ~  0  30 
3T3  2  0 
SV101  8  208 
FISV11  1  10 
Col 2  1  0 
A3~7  16  34 
LS6  19  438 
The release of soluble plasminogen activator and total 
cell-associated  plasminogen  activator were  assayed  as 
described in Materials and Methods and the legend to 
Table I. 
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FIGURE 3  Fibrinolytic  activity  of the  Swiss 3T3  cell 
line, an SV40 transformant  (SV101) of 3T3, and partial 
revertants of SV101.  The fibrinolytic activity of living 
cells plated on 125I-fibrin  coated surfaces was determined 
as described in Materials and Methods and the legend to 
Fig. 1. 
line. However, two other revertants, A 2,7 and LS 
(21), selected by their inability to grow in either 2'- 
globulin-depleted serum or low concentrations of 
serum,  both secreted as much  or more  PA than 
the  parental SV101  line. Thus,  while  the  SV40 
transformant of the Swiss 3T3 cell line did show an 
increased fibrinolysis, revertants of this transform- 
ant did not uniformly produce less PA. The level 
of PA production by these four revertants corre- 
lated with the anchorage requirement of the cells. 
F1SV11  and Col 2 are unable to grow suspended 
in Methocel  (The  Dow  Chemical Co.,  Midland, 
Mich.), while the revertant clones A  2'7 and LS 
studied here retain the ability to grow in Metho- 
cel, a property associated with the original trans- 
formant. 
The  low  fibrinolytic activities associated  with 
3T3  and  the  anchorage  revertant  F1SVll  may 
have been due to the production of an extracellu- 
lar  inhibitor  of fibrinolysis. This  was  tested  by 
plating together pairs of cell lines with different 
levels of PA and assaying the fibrinolytic activity. 
The  fibrinolytic activities of various mixtures of 
nontransformed, revertant, and transformed cells 
were equivalent to the sum of activities associated 
with each cell type (results not shown). Thus, no 
soluble inhibitor of fibrinolysis was found. 
DISCUSSION 
Tumorigenicity and Plasminogen Activator 
The experiments described in this paper demon- 
strate  that  some  established cell lines and  their 
transformants do not necessarily conserve the cor- 
relation between the production of PA and neo- 
plastic transformation, a  consistent finding when 
fibroblasts and primary tumors are examined (13, 
16).  The  lack  of  uniform  correlation  between 
transformation and the production of PA is most 
apparent within cell lines derived from  BALB/c 
3T3. Most of the transformed lines examined syn- 
thesized no more PA than the parental nontrans- 
formed BALB/c 3T3  A31CL10 cells. Several of 
these cell lines, such as KA31, were highly tumori- 
genic even though they synthesized low levels of 
PA, demonstrating that the increased synthesis of 
PA after transformation is not a  prerequisite for 
tumor growth.  Moreover, cell lines derived from 
these  tumors also  produced levels of PA essen- 
tially equivalent  to  the  parental cells, indicating 
that there  was no selection during tumorigenesis 
for rare cells capable of synthesizing high levels of 
PA. 
Although all transformed cell lines derived from 
the BALB/c 3T3  line do not appear to produce 
more PA than the parental cell line, a tumorigenic 
transformant of the  Swiss 3T3  cell line, SV101, 
did  show  a  much  higher  level  of  PA  than  the 
parental cell. Two  phenotypic partial revertants 
selected by different mechanisms but still anchor- 
age transformed, also still produced large amounts 
of PA, again demonstrating the variability of dif- 
ferent  cell  lines  with  respect  to  PA  synthesis. 
Tumorigenicity  of  the  Swiss  3T3  cell lines  has 
been  determined  in  nude  mice  (17).  Here,  the 
correlation between  tumorigenicity and  PA pro- 
duction  is good.  Two  cell lines that  synthesized 
large amounts of PA (A 2'7, and SV101) produced 
tumors upon injection into nude mice, while two 
lines that synthesized little PA (3T3, (Col 2), and 
F1SVII) were not tumorigenic (12). However, LS 
6,  a  revertant of SV101  which synthesized large 
amounts of PA, was not tumorigenic. 
Properties of Cell Lines 
We have no explanation for the discrepancy in 
PA  production  between  cell  lines  and  primary 
transformants.  The  lack  of correlation  between 
transformation and PA production in established 
cell lines has also been described by Mott et al. 
(9). Since a large proportion of tumors do produce 
PA (10, 20, 4), we conclude that when a lack of 
correlation between transformation and PA pro- 
duction is observed (Tables II and III), it may be 
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intrinsic to established cell lines. 
In the establishment  of cell lines from primary 
cultures of normal cells, genetic alterations of un- 
known  nature  must  take  place  since  established 
cell  lines  differ  from  primary  cells  in  many  re- 
spects.  For example,  primary  cultures  of diploid 
cells have a finite life in culture while cell lines are 
capable of infinite growth, a property usually asso- 
ciated  with  transformation  and/or  malignancy. 
Moreover, the  many different assays  used  to  de- 
termine  in  vitro  transformation  detect  separable 
phenotypic alterations (15). A  striking example of 
this can be seen with the SV101 revertants LS and 
A~/7, which have lost the phenotypic properties of 
transformation that were selected against but have 
retained other transformed characteristics such as 
tumorigenicity and anchorage-independence  (17). 
Thus,  it is not surprising  that cell lines ordinarily 
classified as nontransformed,  such as BALB 3T3 
cells, may in fact be malignant (2).  Alterations in 
the  genotype  may  also  accumulate  during  pro- 
longed  culturing  of  cell  lines  and  thus  obscure 
certain  fundamental  phenotypic  changes  that  oc- 
cur after transformation (7). Properties such as the 
synthesis of high levels of proteases  may well be 
selected against in view of the reduced adherence 
of cells to the surface of the petri dish (7). 
These  considerations  as well as other observa- 
tions  on  the  variable  nature  of both  phenotypic 
and  biochemical  correlations  associated  with 
transformation (4,  19, 20, 21) give reason for cau- 
tion in the use of cell lines for studies of malignant 
transformation. 
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